A selective dopamine D4 receptor antagonist, NRA0160: a preclinical neuropharmacological profile (Q28377138)

2

0 references

S Chaki

3

0 references

R Yoshikawa

4

0 references

T Funakoshi

5

0 references

S I Ogawa

6

0 references

Y Suzuki

7

0 references

Y Ikeda

8

0 references

T Kumagai

9

0 references

A Nakazato

10

0 references

M Nagamine

11

0 references

K Tomisawa

Cellular distribution of the rat D4 dopamine receptor protein in the CNS using anti-receptor antisera

12

0 references

language of work or name

English

0 references

publication date

1999

0 references

published in

Life Sciences

0 references

volume

65

0 references

issue

20

0 references

page(s)

2109-25

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900476-2

Prepulse inhibition of the acoustic startle response of rats is reduced by 6-hydroxydopamine lesions of the medial prefrontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900476-2

Clozapine: neuroleptic-induced EPS and tardive dyskinesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900476-2

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900476-2

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900476-2

Autoradiographic localization of the putative D4 dopamine receptor in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900476-2

Distribution of D4 dopamine receptor in rat brain with sequence-specific antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900476-2

Startle response models of sensorimotor gating and habituation deficits in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900476-2

Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900476-2

Molecular cloning, stable expression and desensitization of the human dopamine D1b/D5 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900476-2

Recent advances in the phencyclidine model of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900476-2

[3H]MDL 100,907: a novel selective 5-HT2A receptor ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900476-2

The effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia. D4 Dopamine Antagonist Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900476-2

Dopamine D4 versus D2 receptor selectivity of dopamine receptor antagonists: possible therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900476-2

Selective dopamine D4 receptor antagonists reverse apomorphine-induced blockade of prepulse inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900476-2

Localization of dopamine D4 receptors in GABAergic neurons of the primate brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900476-2

Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900476-2

A rat model of phencyclidine psychosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900476-2

Effect of NE-100, a novel sigma receptor ligand, on phencyclidine-induced cognitive dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900476-2

NE-100, a novel sigma receptor ligand: in vivo tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900476-2

Effect of NE-100, a novel sigma receptor ligand, on phencyclidine- induced delayed cognitive dysfunction in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900476-2

Developments in the drug treatment of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900476-2

Are Striatal Dopamine D4 Receptors Increased in Schizophrenia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900476-2

A systematized approach to the management of the depressed and anxious patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900476-2

Dopamine D4 receptors elevated in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900476-2

Schizophrenia: elevation of dopamine D4-like sites, using [3H]nemonapride and [125I]epidepride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900476-2

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900476-2

Elevation of D4 dopamine receptor mRNA in postmortem schizophrenic brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900476-2

Dopamine D4 receptors and effects of guanine nucleotides on [3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900476-2

Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900476-2

SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900476-2

Limbic System Abnormalities Identified in Schizophrenia Using Positron Emission Tomography With Fluorodeoxyglucose and Neocortical Alterations With Deficit Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900476-2

Localization of dopamine receptor subtypes in corpus striatum and nucleus accumbens septi of rat brain: comparison of D1-, D2-, and D4-like receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900476-2

Regional distribution of dopamine D4 receptors in rat forebrain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900476-2

Treatment of positive and negative symptoms: pharmacologic approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900476-2